Number of patient participants needed for secondary approval of a new cancer drug.
First-in-class oral drug improves embryo implantation and pregnancy outcomes in IVF
New research has demonstrated the effectiveness of a first-in-class oral, non-hormonal drug in increasing embryo implantation, pregnancy and live birth rates among infertile women who